A two-for-one deal: both cardiovascular benefits and renal protection.
Read More »DKA Leads to Changes in Children’s Cognitive Function
Just one incident of DKA could potentially damage memory in children with type 1 diabetes.
Read More »Glycemic and Adiposity Benefits with Metformin Use in Pregnancy
A placebo-controlled trial was conducted to determine fetal, neonatal, and maternal outcomes associated with metformin use during pregnancy in women with T2DM.
Read More »How Disordered Eating and Diabetes are Related
People with diabetes may be predisposed to a variety of eating disorders, such as binge eating.
Read More »Excessive Bleeding after Injection Raises Suspicions
A man 79 years of age was referred to me to start insulin. As a diabetes educator, I don't always have a full history and comprehensive labs given to me from the PCP. I met the patient and his family who told me his history, medications, lifestyle, etc....
Read More »Common Diabetes Medication as Treatment for Parkinson’s Disease
Findings show Parkinson’s disease risk is reduced in patients with type 2 diabetes mellitus (T2DM) after treatment with exenatide.
Read More »Brain Damage Associated with High Blood Glucose
Researchers continue to uncover the many ways uncontrolled hyperglycemia can damage the body.
Read More »Left Ventricular Mass Reduction and Empagliflozin
Empagliflozin significantly lowered LVMi, systolic blood pressure, and diastolic blood pressure in patients with CAD and type 2 diabetes.
Read More »Ethnicity Can Affect Risk for Diabetes Complications
A diabetes patient’s risk for chronic kidney disease or cardiovascular disease can be impacted by various factors, including ethnic background.
Read More »Improved Post-Surgical Outcomes in Patients Using Metformin
Metformin use was associated with lower inflammatory markers before surgery, leading to improved outcomes post-surgery.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.